leadf
logo-loader
viewWillow Biosciences Inc.

Willow Biosciences announces game changing successful production of pure CBG in 500 litre scale

Willow Biosciences (TSE: WLLW-OTCQX: CANSF) President and CEO Trevor Peters joined Steve Darling from Proactive with news the company has successfully developed a scalable process for producing cannabigerol with greater than 99% purity and no detectable THC at 500-litre scale.

Peters discusses why this is so important and when they are hoping to begin commercialization of CBG.

Quick facts: Willow Biosciences Inc.

Price: 0.54 CAD

TSX:WLLW
Market: TSX
Market Cap: $42.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Willow Biosciences Inc. named herein, including the promotion by the Company of Willow Biosciences Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Willow Bioscience takes first major step towards development of...

Willow Bioscience (TSE: WLLW: OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive Vancouver with news the company has hit a major milestone in their development. Peters talks about this significant step. Peters also talked about the company as a whole and what separates them...

on 07/29/2020

2 min read